Olympic Protein Technologies

Executive Summary

Olympic Protein Technologies (OPT) is a US-based contract research organization (CRO) specializing in custom recombinant protein production and characterization. Founded in 2015 in Portland, OPT offers DNA sequence optimization, multiple expression systems, and comprehensive services from molecular biology to biomolecular interaction analysis. Its focus on high-quality protein and antibody production positions it as a partner for academic and biopharma researchers. The company operates in the growing outsourced protein services market, driven by increasing R&D spending and demand for biologics. However, OPT faces intense competition from larger CROs and must differentiate through technical expertise and client relationships. Its private status limits visibility, but steady demand for custom proteins provides a stable revenue base. Key risks include reliance on a few large clients and technological obsolescence.

Upcoming Catalysts (preview)

• Q4 2026Launch of advanced protein engineering services70% success
• TBDStrategic partnership with a mid-size biopharma company50% success
• Q3 2026Achievement of ISO 9001 certification80% success